Molecular Pathology in Epidemiologic Studies: A Primer on Key Considerations
Open Access
- 1 April 2010
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 19 (4), 966-972
- https://doi.org/10.1158/1055-9965.epi-10-0056
Abstract
The development of molecular pathologic components in epidemiologic studies offers opportunities to relate etiologic factors to specific tumor types, which in turn may allow the development of better overall risk prediction and provide clues about mechanisms that mediate risk factors. In addition, this research may help identify or validate tissue biomarkers related to prognosis and prediction of treatment responses. In this mini review, we highlight specific considerations related to the incorporation of pathology in epidemiologic studies, using breast cancer research as a model. Issues related to ensuring the representativeness of cases for which research tissue is available and understanding limitations resulting from variable procedures for tissue collection, fixation, and processing are discussed. The growing importance of molecular pathology in clinical medicine has led to increased emphasis on optimized tissue preparation, which should enhance this type of research. In addition, the availability of new technologies including tissue microarrays, image scanning, and automated analysis to achieve high-throughput standardized assessment of immunohistochemical markers, and potentially other assays, is enabling consistent scoring of a growing list of markers in large studies. Concurrently, methodologic research to extend the range of assays that can be done on fixed tissues is expanding possibilities for molecular pathologic studies in epidemiologic research. Cancer Epidemiol Biomarkers Prev; 19(4); 966–72. ©2010 AACR.This publication has 44 references indexed in Scilit:
- The Impact of Tissue Fixatives on Morphology and Antibody-based Protein Profiling in Tissues and CellsJournal of Histochemistry & Cytochemistry, 2009
- DNA Hypermethylation ofESR1andPGRin Breast Cancer: Pathologic and Epidemiologic AssociationsCancer Epidemiology, Biomarkers & Prevention, 2009
- 2009 Biospecimen Research Network Symposium: Advancing Cancer Research through Biospecimen ScienceCancer Research, 2009
- Underlying Causes of the Black-White Racial Disparity in Breast Cancer Mortality: A Population-Based AnalysisJNCI Journal of the National Cancer Institute, 2009
- Recommendations for Collection and Handling of Specimens From Group Breast Cancer Clinical TrialsJournal of Clinical Oncology, 2008
- Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsiesCancer, 2008
- Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue respository of the Surveillance, Epidemiology, and End Results (SEER) programBreast Cancer Research and Treatment, 2008
- Established breast cancer risk factors by clinically important tumour characteristicsBritish Journal of Cancer, 2006
- Long-term preservation of antigenicity on tissue microarraysLaboratory Investigation, 2004
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998